Rheumatoid meningitis as a complication of long-standing rheumatoid arthritis: a case treated with rituximab. 2021

Iván Del Bosque Granero, and Jesús Loarce-Martos, and María Ángeles Blázquez Cañamero, and Francisco Javier Buisan Catevilla, and Montserrat Medina Díaz, and Francisco Javier Bachiller-Corral
Department of Rheumatology, Ramón y Cajal University Hospital, Madrid, Spain.

Rheumatoid meningitis is a rare complication of long-standing rheumatoid arthritis. We present the case of a 39-year-old Bolivian woman with a history of seropositive rheumatoid arthritis of 12 years of evolution without extra-articular manifestations that develops a severe headache with vomiting. The diagnosis of rheumatoid meningitis was performed based on clinical history, blood count and biochemistry results, cerebrospinal fluid analysis and cranial magnetic resonance imaging findings. High-dose intravenous glucocorticoids were started, followed by rituximab. After treatment, a significant clinical improvement was observed and repeat magnetic resonance imaging scan confirmed an improvement of the meningeal lesions.

UI MeSH Term Description Entries
D008581 Meningitis Inflammation of the coverings of the brain and/or spinal cord, which consist of the PIA MATER; ARACHNOID; and DURA MATER. Infections (viral, bacterial, and fungal) are the most common causes of this condition, but subarachnoid hemorrhage (HEMORRHAGES, SUBARACHNOID), chemical irritation (chemical MENINGITIS), granulomatous conditions, neoplastic conditions (CARCINOMATOUS MENINGITIS), and other inflammatory conditions may produce this syndrome. (From Joynt, Clinical Neurology, 1994, Ch24, p6) Pachymeningitis,Meningitides,Pachymeningitides
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000069283 Rituximab A murine-derived monoclonal antibody and ANTINEOPLASTIC AGENT that binds specifically to the CD20 ANTIGEN and is used in the treatment of LEUKEMIA; LYMPHOMA and RHEUMATOID ARTHRITIS. CD20 Antibody, Rituximab,GP2013,IDEC-C2B8,IDEC-C2B8 Antibody,Mabthera,Rituxan,IDEC C2B8,IDEC C2B8 Antibody,Rituximab CD20 Antibody
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001172 Arthritis, Rheumatoid A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated. Rheumatoid Arthritis

Related Publications

Iván Del Bosque Granero, and Jesús Loarce-Martos, and María Ángeles Blázquez Cañamero, and Francisco Javier Buisan Catevilla, and Montserrat Medina Díaz, and Francisco Javier Bachiller-Corral
May 2010, Clinical rheumatology,
Iván Del Bosque Granero, and Jesús Loarce-Martos, and María Ángeles Blázquez Cañamero, and Francisco Javier Buisan Catevilla, and Montserrat Medina Díaz, and Francisco Javier Bachiller-Corral
July 2015, BMJ case reports,
Iván Del Bosque Granero, and Jesús Loarce-Martos, and María Ángeles Blázquez Cañamero, and Francisco Javier Buisan Catevilla, and Montserrat Medina Díaz, and Francisco Javier Bachiller-Corral
March 2008, Pathology oncology research : POR,
Iván Del Bosque Granero, and Jesús Loarce-Martos, and María Ángeles Blázquez Cañamero, and Francisco Javier Buisan Catevilla, and Montserrat Medina Díaz, and Francisco Javier Bachiller-Corral
September 2011, Rheumatology (Oxford, England),
Iván Del Bosque Granero, and Jesús Loarce-Martos, and María Ángeles Blázquez Cañamero, and Francisco Javier Buisan Catevilla, and Montserrat Medina Díaz, and Francisco Javier Bachiller-Corral
September 2021, Cureus,
Iván Del Bosque Granero, and Jesús Loarce-Martos, and María Ángeles Blázquez Cañamero, and Francisco Javier Buisan Catevilla, and Montserrat Medina Díaz, and Francisco Javier Bachiller-Corral
January 2023, Frontiers in immunology,
Iván Del Bosque Granero, and Jesús Loarce-Martos, and María Ángeles Blázquez Cañamero, and Francisco Javier Buisan Catevilla, and Montserrat Medina Díaz, and Francisco Javier Bachiller-Corral
June 2019, Archives of rheumatology,
Iván Del Bosque Granero, and Jesús Loarce-Martos, and María Ángeles Blázquez Cañamero, and Francisco Javier Buisan Catevilla, and Montserrat Medina Díaz, and Francisco Javier Bachiller-Corral
June 2016, Internal medicine journal,
Iván Del Bosque Granero, and Jesús Loarce-Martos, and María Ángeles Blázquez Cañamero, and Francisco Javier Buisan Catevilla, and Montserrat Medina Díaz, and Francisco Javier Bachiller-Corral
June 2009, Autoimmunity reviews,
Iván Del Bosque Granero, and Jesús Loarce-Martos, and María Ángeles Blázquez Cañamero, and Francisco Javier Buisan Catevilla, and Montserrat Medina Díaz, and Francisco Javier Bachiller-Corral
May 2011, Rheumatology international,
Copied contents to your clipboard!